Overview
Title
Center for Scientific Review; Amended Notice of Meeting
Agencies
ELI5 AI
The National Institutes of Health decided to start a special meeting about cancer genetics a little later than originally planned. Instead of beginning at 8:00 a.m., it will now start at 9:30 a.m., but it will still be in the same place in Bethesda, Maryland, and it won't be open for everyone to come and watch.
Summary AI
The National Institutes of Health announced a change to the meeting schedule of the Cancer Genetics Study Section. The meeting, originally set to start at 8:00 a.m. on February 22, 2021, will now start at 9:30 a.m., ending the next day at 5:00 p.m., but the location remains the same at Rockledge Drive, Bethesda, MD. This announcement was previously reported in the Federal Register on January 22, 2021, and the meeting remains closed to the public.
Keywords AI
Sources
AnalysisAI
Summary of the Document
The document is a notice from the National Institutes of Health (NIH) regarding a scheduling change for the Cancer Genetics Study Section meeting. Initially set to begin at 8:00 a.m. on February 22, 2021, the meeting will instead commence at 9:30 a.m. on the same day and will last until 5:00 p.m. on February 23, 2021. The venue remains unchanged and it will be held at Rockledge Drive in Bethesda, Maryland. The meeting is closed to the general public. This amendment was documented in an earlier notice published in the Federal Register on January 22, 2021.
Significant Issues or Concerns
There are no significant issues or concerns apparent from this notice. It is a straightforward update concerning the timing of a previously scheduled meeting. The critical change is the adjustment in the meeting's start time. Since the meeting remains closed to the public, this schedule change may not have a wide-reaching impact.
Impact on the Public
Given that the meeting is closed to the public, this notice is unlikely to broadly affect the general populace. It primarily serves to inform those directly involved or interested parties who might be tracking such meetings for professional, research, or scholarly purposes.
Impact on Specific Stakeholders
For stakeholders such as researchers, healthcare professionals, or policymakers with an interest in cancer genetics, this meeting is of significance. The revised timing could require affected participants to adjust their schedules accordingly. Despite being closed to the public, stakeholders might be indirectly impacted by discussions and outcomes from the meeting if they influence future NIH policies, research directions, or funding allocations in cancer genetics. Such decisions could ultimately shape the landscape of cancer research and potential treatment innovations, which would eventually trickle down benefits to patients and those working in oncology fields.
In summary, while this notice may not directly affect the public presently, its implications could echo through subsequent policies and research developments, underscoring the importance of efficient communication and scheduling by the involved federal organizations.